Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis

The second messenger 2′3′-cyclic-GMP-AMP (cGAMP) is thought to be transmitted from brain carcinomas to astrocytes via gap junctions, which functions to promote metastasis in the brain parenchyma. In the current study, we established a method to introduce cGAMP into astrocytes, which simulates the st...

Full description

Bibliographic Details
Main Authors: Toya Okawa, Kurumi Hara, Momoko Goto, Moe Kikuchi, Masataka Kogane, Hiroto Hatakeyama, Hiroki Tanaka, Daiki Shirane, Hidetaka Akita, Akihiro Hisaka, Hiromi Sato
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/16/9028
id doaj-4d809ad0da4e41ec86d595507387be36
record_format Article
spelling doaj-4d809ad0da4e41ec86d595507387be362021-08-26T13:53:42ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-08-01229028902810.3390/ijms22169028Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain MetastasisToya Okawa0Kurumi Hara1Momoko Goto2Moe Kikuchi3Masataka Kogane4Hiroto Hatakeyama5Hiroki Tanaka6Daiki Shirane7Hidetaka Akita8Akihiro Hisaka9Hiromi Sato10Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanDesign and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanDesign and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanDesign and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanThe second messenger 2′3′-cyclic-GMP-AMP (cGAMP) is thought to be transmitted from brain carcinomas to astrocytes via gap junctions, which functions to promote metastasis in the brain parenchyma. In the current study, we established a method to introduce cGAMP into astrocytes, which simulates the state of astrocytes that have been invaded by cGAMP around tumors. Astrocytes incorporating cGAMP were analyzed by metabolomics, which demonstrated that cGAMP increased glutamate production and astrocyte secretion. The same trend was observed for γ-aminobutyric acid (GABA). Conversely, glutamine production and secretion were decreased by cGAMP treatment. Due to the fundamental role of astrocytes in regulation of the glutamine–glutamate cycle, such metabolic changes may represent a potential mechanism and therapeutic target for alteration of the central nervous system (CNS) environment and the malignant transformation of brain carcinomas.https://www.mdpi.com/1422-0067/22/16/9028cGAMPmetabolome shiftastrocytemetastatic brain tumorglutamate
collection DOAJ
language English
format Article
sources DOAJ
author Toya Okawa
Kurumi Hara
Momoko Goto
Moe Kikuchi
Masataka Kogane
Hiroto Hatakeyama
Hiroki Tanaka
Daiki Shirane
Hidetaka Akita
Akihiro Hisaka
Hiromi Sato
spellingShingle Toya Okawa
Kurumi Hara
Momoko Goto
Moe Kikuchi
Masataka Kogane
Hiroto Hatakeyama
Hiroki Tanaka
Daiki Shirane
Hidetaka Akita
Akihiro Hisaka
Hiromi Sato
Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis
International Journal of Molecular Sciences
cGAMP
metabolome shift
astrocyte
metastatic brain tumor
glutamate
author_facet Toya Okawa
Kurumi Hara
Momoko Goto
Moe Kikuchi
Masataka Kogane
Hiroto Hatakeyama
Hiroki Tanaka
Daiki Shirane
Hidetaka Akita
Akihiro Hisaka
Hiromi Sato
author_sort Toya Okawa
title Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis
title_short Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis
title_full Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis
title_fullStr Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis
title_full_unstemmed Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis
title_sort effects on metabolism in astrocytes caused by cgamp, which imitates the initial stage of brain metastasis
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-08-01
description The second messenger 2′3′-cyclic-GMP-AMP (cGAMP) is thought to be transmitted from brain carcinomas to astrocytes via gap junctions, which functions to promote metastasis in the brain parenchyma. In the current study, we established a method to introduce cGAMP into astrocytes, which simulates the state of astrocytes that have been invaded by cGAMP around tumors. Astrocytes incorporating cGAMP were analyzed by metabolomics, which demonstrated that cGAMP increased glutamate production and astrocyte secretion. The same trend was observed for γ-aminobutyric acid (GABA). Conversely, glutamine production and secretion were decreased by cGAMP treatment. Due to the fundamental role of astrocytes in regulation of the glutamine–glutamate cycle, such metabolic changes may represent a potential mechanism and therapeutic target for alteration of the central nervous system (CNS) environment and the malignant transformation of brain carcinomas.
topic cGAMP
metabolome shift
astrocyte
metastatic brain tumor
glutamate
url https://www.mdpi.com/1422-0067/22/16/9028
work_keys_str_mv AT toyaokawa effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis
AT kurumihara effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis
AT momokogoto effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis
AT moekikuchi effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis
AT masatakakogane effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis
AT hirotohatakeyama effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis
AT hirokitanaka effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis
AT daikishirane effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis
AT hidetakaakita effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis
AT akihirohisaka effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis
AT hiromisato effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis
_version_ 1721192470961717248